CoChat

Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence

Open access
Preiss, David, Sattar, Naveed · 2009 · Clinical Endocrinology
Cited by 82

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

Summary: It is well‐established that serum total‐cholesterol, LDL‐cholesterol, low HDL‐cholesterol and calculated indices such as total cholesterol : HDL‐cholesterol ratio or less commonly used indices such as non‐HDL cholesterol are strongly predictive of cardiovascular events. Serum triglycerides, by contrast, are only modestly associated with coronary heart disease (CHD) in multivariate analysis and incorporation of triglycerides into prediction algorithms is therefore unlikely to improve their prediction capability. Meta‐analysis of studies including > 90 000 subjects has provided robust evidence that statins reduce important clinical end‐points. These included a 12% fall in all‐cause mortality, 19% fall in CHD mortality and 23% fall in CHD mortality or myocardial infarction. Furthermore there are high quality data showing additional benefit of intensive statin therapy over standard statin therapy for secondary prevention of cardiovascular disease. However, meta‐analysis of 10 fibrate trials has shown inconsistent evidence of vascular benefit and non‐cardiovascular mortality has been slightly but consistently elevated in most fibrate trials and in meta‐analysis. The general use of fibrates for cardiovascular risk reduction can therefore not be supported at present. Other second line agents such as bile acid sequestrants, nicotinic acid and omega‐3 fatty acid supplements have been evaluated in a few randomized controlled studies in which cardiovascular benefit has been found but clearly further data are required to properly establish their use in clinical practice. Ongoing studies such as ACCORD, IMPROVE‐IT, ASCEND, ORIGIN and HPS2‐THRIVE should assist in answering outstanding questions over the next 5 years.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2008.03490.x

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Cited by

See all 82

Metadata

Authors
Preiss, D., & Sattar, N.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2009-05-13
Volume
70
Issue
6
Pages
815-828
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2016838830
Cited by
82
References
40
FWCI
12.28
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence. https://app.cochat.ai/papers/10.1111/j.1365-2265.2008.03490.x
The paper
Preiss, D., & Sattar, N. (2009). Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2008.03490.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.